Subscribe to our Newsletters !!
Infections pose an everpresent threat to society a
In the current world of biotechnology, inefficienc
The Nobel Prize in Physiology or Medicine awarded
Giesen, Germany. 26 January 2026 - At Interpack 20
Alembic Pharmaceuticals Limited (Alembic) today an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micr
British drugmaker AstraZeneca Plc told Reuters on Tuesday that its COVID-19 vaccine should be effective against the new coronavirus version, including that studies were under way to completely probe the effect of the mutation.
“AZD1222 (AstraZeneca’s vaccine candidate) contains the genetic material of this SARS-CoV-2 virus spike protein, as well as the changes to the genetic code found in this viral strain do not seem to modify the structure of the spike protein,” an AstraZeneca spokesperson said in an email.